Martha Court joins Salus Wellness
The team at Salus are pleased to announce that Martha Court has joined Salus Wellness this month.
Norovirus vaccines - closer than you think
This month VacZine Analytics, a specialist in infectious diseases and vaccines commercial analysis, publishes a brand-new global demand assessment for new norovirus vaccines.
CN Bio introduces cross-species DILI services to enhance in vitro to in vivo extrapolation during preclinical drug development
CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, has introduced two new animal microphysiological system (MPS) models that enhance translatability in preclinical drug safety and toxicology assessments to its C
Enhanced Genomics appoints Dietrich Stephan, Ph.D. as Chair of the Board to lead ambitious growth strategy
Appointment strengthens leadership team to drive strategy focused on harnessing 3D multi-omics to identify high-confidence, high-value therapeutic targets, to accelerate drug discovery
Kerry Elden joins Salus Wellness
The team at Salus are pleased to announce that Kerry Elden has joined Salus Wellness this month.
Tagomics awarded £860k Innovate UK Biomedical Catalyst grant for detection of colorectal cancer
Grant forms part of £1.2M project to customise Tagomics’ multiomic profiling platform for early detection of colorectal cancerEarly detection test to be developed in collaboration with the Salford Royal NHS Foundation Trust and the Northern Care Alliance Research Collection biobank
Centauri Therapeutics publishes proof-of-concept data demonstrating activity of a novel bifunctional immunotherapy against Gram-negative bacterial infections
Paper presents the first pre-clinical application of endogenous antibody recruitment to address multi-drug resistant Gram-negative infectionsNovel bifunctional molecule based on Alphamer platform demonstrated direct, broad-spectrum antibacterial activity in vitro and in vivo, with e
Supporting our clients globally - Team Consulting welcomes David Maltz
As part of our continued international growth, Team Consulting is pleased to welcome David Maltz as the newest member of our commercial team.
How to prove the ROI of your content marketing in science and tech
Avoid another awkward boardroom moment where the marketing ROI question leaves you fumbling- this article shows you how to prove your content’s impact with clarity and confidence.
Cambridge NeuroWorks Fellows showcase innovation at connecting neuroscience workshop
Cambridge NeuroWorks Fellows had a brilliant opportunity to showcase their research at the Cambridge NeuroWorks Connecting Neuroscience event, held in collaboration with Cambridge Neuroscience and Cambridge Network.
Cambridge plays host to global gathering on Parkinson’s research
Cambridge continues to prove itself as a world-class destination for conferences, as it welcomed the prestigious Alpha Synuclein Conference.
Shift Bioscience identifies novel single-gene target for safer cellular rejuvenation therapeutics
SB000 reverses cellular ageing as measured by DNA methylation clocks in multiple cell types without loss of cellular identity or signs of pluripotencyStudy advances efforts towards next-generation rejuvenation therapeutics with applications across age-driven diseas
What it takes to get ahead in biotech
By Priya Kalia, SciTribe and Miranda Weston-Smith, BioBeat.
Brain injury survivors help shape new medical technologies
Researchers based at Cambridge University Hospitals NHS Foundation Trust (CUH) have developed a programme to ensure that the development of medical technology is in line with the unmet needs of brain injury survivors.
“Think like a car salesperson”: What biotech and AI start-ups can learn about selling
For many UK start-ups in biotech and AI, selling doesn’t come naturally. Founders are often scientists, engineers, developers or researchers, brilliant at building, but less comfortable with business. Yet, no matter how innovative your product is, it won’t make an impact unless someone buys it. To explore how technical founders can become more effective at sales, we spoke with Gary Jennings,…
Baby’s microbiome may protect against childhood viral infection
A baby's makeup of gut bacteria — their microbiome — which starts to form as soon as they are born, could help protect against viral infections later in childhood, a new study suggests.
Blue Smile celebrates 15 years of supporting children's mental health
Local charity Blue Smile celebrated its 15th anniversary on 28th May with a reception hosted by Downing College, Cambridge.
Overcoming challenges in Pulmonary Hypertension
Pulmonary hypertension (PH) is a rare, progressive, debilitating condition characterised by elevated pulmonary artery pressure [1].
How to build a content strategy that works: A guide for science and tech marketers
It’s not enough to have great content for science and tech marketers - you need a strategy that aligns with your commercial goals and drives real ROI. So how do you build one?
AI-driven multiomics in health: our 2025 roundtable insights
We recently convened a multidisciplinary group of health clinicians, researchers, academics, policy makers and industry professionals to find out where they are using - or expect to use -AI-driven multiomics, and where barriers to uptake lie.
The EpiCentre Haverhill to host Cambridge wide open day on 11th June
New venue announcement for Cambridge Wide Open Day! The EpiCentre is proud to open its doors for a morning of networking, innovation, and discovery. As part of this exciting day, we’re featuring a special showcase from one of our pioneering companies – KluraLabs.
Fujifilm rebrands life sciences companies to strengthen position as strategic Partners for Life, offering end-to-end solutions
FUJIFILM Irvine Scientific becomes FUJIFILM Biosciences, providing a full spectrum of life sciences solutions built from a 55-year history as a cell culture pioneer FUJIFILM Diosynth Biotechnologies will be known as FUJIFILM Biotechnologies, serving global partners seek
Ireland adopts Cambridge-developed method to monitor early prostate cancer
Development of the first evidence-based tool that helps clinicians actively monitor early prostate cancer in newly diagnosed patients has won important recognition in Ireland following research in Cambridge.
The strategic importance of private 5G networks
In the rapidly evolving landscape of emergency response, connectivity, reliability, and security are paramount. Private 5G networks are emerging as a transformative force, providing first responders across the United States with unprecedented communication capabilities.
Dinosaurs could hold key to cancer discoveries
New study highlights the importance of preserving fossilised soft tissues.